| Authors: |
Bergerot PG; Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil. Electronic address: paulobergerot@gmail.com., Bergerot CD; Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil., Silva JRG; Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil., Franca MVS; Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil., Hundal J; Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA., Fuzita WH; Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil., Lages PS; Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil., Dos Anjos G; Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil., de Azeredo AC; Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil., Patriota CB; Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil., Buso MM; Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil., Philip EJ; University of California Los Angeles, Los Angeles, CA, USA., Schmitz KH; University of Pittsburgh, Pittsburgh, PA, USA., Florez N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Soto-Perez-de-Celis E; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Denver, CO, USA. |
